Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
by on Friday, August 10th, 2012 | No Comments
Condition: Multiple Myeloma
Intervention: Drug: High-Dose Melphalan HCL for Injection (Propylene Glycol-Free)
Sponsors: Ligand Pharmaceuticals; Ligand Pharmaceuticals; Clinipace LTD; Kansas City Bioanalytical Laboratories; Beckloff Associates, Inc.
Not yet recruiting – verified August 2012
Go here to read the rest: Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation